338 related articles for article (PubMed ID: 9839090)
1. Continuous infusion of beta-lactam antibiotics.
MacGowan AP; Bowker KE
Clin Pharmacokinet; 1998 Nov; 35(5):391-402. PubMed ID: 9839090
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Moczygemba LR; Frei CR; Burgess DS
Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.
Burgess DS; Hastings RW; Hardin TC
Clin Ther; 2000 Jan; 22(1):66-75. PubMed ID: 10688391
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
Sumitani Y; Kobayashi Y
Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of antimicrobial agents and rationale for their dosing.
MacGowan AP; Bowker KE
J Chemother; 1997 May; 9 Suppl 1():64-73. PubMed ID: 9248964
[TBL] [Abstract][Full Text] [Related]
7. Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations.
Mouton JW; Vinks AA
J Antimicrob Chemother; 1996 Jul; 38(1):5-15. PubMed ID: 8858451
[TBL] [Abstract][Full Text] [Related]
8. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
10. Part II. Introduction to the beta-lactam antibiotics.
Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
[No Abstract] [Full Text] [Related]
11. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children.
Rappaz I; Decosterd LA; Bille J; Pilet M; Bélaz N; Roulet M
Eur J Pediatr; 2000 Dec; 159(12):919-25. PubMed ID: 11131352
[TBL] [Abstract][Full Text] [Related]
13. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactam antibiotics: is continuous infusion the preferred method of administration?
Vondracek TG
Ann Pharmacother; 1995 Apr; 29(4):415-24. PubMed ID: 7633021
[TBL] [Abstract][Full Text] [Related]
16. Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers.
Hollenstein U; Brunner M; Mayer BX; Delacher S; Erovic B; Eichler HG; Müller M
Clin Pharmacol Ther; 2000 Mar; 67(3):229-36. PubMed ID: 10741625
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.
Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH
Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
